Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duragesic Safety and PK in Pediatric Continuous Pain
NCT00271414Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 1999
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, open-label, single-arm trial of fentanyl in chronic pain, sponsored by Janssen Pharmaceutical. Primary endpoints: Incidence and severity of adverse events, Physical examination results and 2 more. Started Mar 1999; status: completed.
02
Drugs
fentanyl
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT00271414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00271414.